All Stories

  1. Preventive Effects of β-Cryptoxanthin, a Potent Antioxidant and Provitamin A Carotenoid, on Lifestyle-Related Diseases—A Central Focus on Its Effects on Non-Alcoholic Fatty Liver Disease (NAFLD)
  2. Exercise Performance Upregulatory Effect of R-α-Lipoic Acid with γ-Cyclodextrin
  3. Multi-Omics Analysis to Generate Hypotheses for Mild Health Problems in Monkeys
  4. Strong Binding Affinity of d-Allulose and Allulosides to Boronic Acids and the Structural Characterization of Their Sugar-boronate Complexes
  5. A Putative Single-Photon Emission CT Imaging Tracer for Erythropoietin-Producing Hepatocellular A2 Receptor
  6. Copper‐mediated radioiodination reaction through aryl boronic acid or ester precursor and its application to direct radiolabeling of a cyclic peptide
  7. Analysis of the predictive factors for a critical illness of COVID-19 during treatment - relationship between serum zinc level and critical illness of COVID-19 −
  8. Synthesis of 18F-labeled streptozotocin derivatives and an in-vivo kinetics study using positron emission tomography
  9. Chelation of zinc(II) with poly(γ-glutamic acid) in aqueous solution: kinetics, binding constant, and its antimicrobial activity
  10. Effects of exercise on biological trace element concentrations and selenoprotein P expression in rats with fructose-induced glucose intolerance
  11. Bright and dark sides of exercise effects on biological responses such as energy metabolism and renal function in rats with renal failure and fructose-induced glucose intolerance
  12. Crystal Structure of Zinc(II) Complexes with 2-Ethyl-3-hydroxy-4H-pyran-4-thione and 2-Ethyl-3-hydroxy-4H-pyran-4-selenone
  13. Pharmacokinetics of Oxaliplatin in a Hemodialysis Patient with Metastatic Colon Cancer
  14. Potential antidiabetic zinc(II) complexes of novel 5-oxo-2-thioxopyrrolidine derivatives synthesized via an unprecedented reaction
  15. Copper accumulation in the brain causes the elevation of oxidative stress and less anxious behavior in Ts1Cje mice, a model of Down syndrome
  16. In Vivo Effect of Bis(Maltolato)Zinc(II) Complex on Akt Phosphorylation in Adipose Tissues of Mice
  17. Predicting organ carotenoids levels from analysis of plasma could lead to errors: A study in cynomolgus monkeys
  18. Global overexpression of divalent metal transporter 1 delays crocidolite-induced mesothelial carcinogenesis in male mice
  19. Investigating the target organs of novel anti-diabetic zinc complexes with organo‑selenium ligands
  20. Efforts to Promote Research Integrity in Academia
  21. Development of a carboplatin derivative conjugated with a collagen-like triple-helical peptide
  22. Vanadium and zinc anti-diabetics
  23. Anti-Diabetic Effect of Organo-Chalcogen (Sulfur and Selenium) Zinc Complexes with Hydroxy-Pyrone Derivatives on Leptin-Deficient Type 2 Diabetes Model ob/ob Mice
  24. Beneficial Effect of Bis(Hinokitiolato)Zn Complex on High-fat Diet-induced Lipid Accumulation in Mouse Liver and Kidney
  25. Expression of human cathelicidin peptide LL-37 in inflammatory bowel disease
  26. Vanadium and zinc anti-diabetics
  27. Frontier of Development for Metallodrugs on the Basis of Metallomic Pharmacology and Medicinal Inorganic Chemistry
  28. Anti-hyperglycemic Effect of Long-Term Bis(hinokitiolato)zinc Complex ([Zn(hkt)<sub>2</sub>]) Ingestion on Insulin Resistance and Pancreatic Islet Cells Protection in Type 2 Diabetic KK-A<sup>y</sup> Mice
  29. Development of New Ligands for the Recyclable Catalytic Asymmetric Transfer Hydrogenation in Ionic Liquid
  30. Investigation of Biodistribution and Speciation Changes of Orally Administered Dual Radiolabeled Complex, Bis(5-chloro-7-[<sup>131</sup>I]iodo-8-quinolinolato)[<sup>65</sup>Zn]zinc
  31. Reaction and Scavenging Mechanism of β-Carotene and Zeaxanthin with Reactive Oxygen Species
  32. Synthesis and biological evaluation of 4-hydroxy-5-oxo-2,5-dihydro-1H-pyrrole-3-carboxamides and their zinc(ii) complexes as candidate antidiabetic agents
  33. Changes in blood concentrations of trace metals in cancer patients receiving cisplatin-based chemotherapy
  34. Transport of Azithromycin into Extravascular Space in Rats
  35. Contrasting intra- and extracellular distribution of catalytic ferrous iron in ovalbumin-induced peritonitis
  36. Reaction of Paprika Carotenoids, Capsanthin and Capsorubin, with Reactive Oxygen Species
  37. Bis(hinokitiolato)zinc complex ([Zn(hkt)2]) activates Akt/protein kinase B independent of insulin signal transduction
  38. Anti-Oxidative Activity of Mytiloxanthin, a Metabolite of Fucoxanthin in Shellfish and Tunicates
  39. Oral treatment with a zinc complex of acetylsalicylic acid prevents diabetic cardiomyopathy in a rat model of type-2 diabetes: activation of the Akt pathway
  40. Analysis of reaction products of astaxanthin and its acetate with reactive oxygen species using LC/PDA ESI-MS and ESR spectrometry
  41. Visualization of biodistribution of Zn complex with antidiabetic activity using semiconductor Compton camera GREI
  42. <i>α</i>-Glucosidase Inhibition by New Schiff Base Complexes of Zn(II)
  43. Administration of zinc complex of acetylsalicylic acid after the onset of myocardial injury protects the heart by upregulation of antioxidant enzymes
  44. Isomeric effects of anti-diabetic α-lipoic acid with γ-cyclodextrin
  45. Superiority of zinc complex of acetylsalicylic acid to acetylsalicylic acid in preventing postischemic myocardial dysfunction
  46. Accumulation of Paprika Carotenoids in Human Plasma and Erythrocytes
  47. A Cisplatin Derivative that Inhibits Collagen Fibril-Formationin vitro
  48. New Insulin-Mimetic and Hypoglycemic Hetero-Binuclear Zinc(II)/ Oxovanadium(IV) Complex
  49. Bis (Aspirinato) Zinc (II) Complex Successfully Inhibits Carotid Arterial Neointima Formation after Balloon-injury in Rats
  50. Development of PEGylated serum albumin with multiple reduced thiols as a long-circulating scavenger of reactive oxygen species for the treatment of fulminant hepatic failure in mice
  51. Zn complex medication provides the morphological and biochemical improvements in type 2 diabetes.
  52. Antidiabetic effect of the α-lipoic acid γ-cyclodextrin complex
  53. Intestinal and Hepatic Expression of Cytochrome P450s and mdr1a in Rats with Indomethacin-Induced Small Intestinal Ulcers
  54. Potential of collagen-like triple helical peptides as drug carriers: Their in vivo distribution, metabolism, and excretion profiles in rodents
  55. Deferasirox Induces Mesenchymal–Epithelial Transition in Crocidolite-Induced Mesothelial Carcinogenesis in Rats
  56. Development of a novel antidiabetic zinc complex with an organoselenium ligand at the lowest dosage in KK-Ay mice
  57. Mechanism of Retinoid X Receptor Partial Agonistic Action of 1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-1H-benzotriazole-5-carboxylic Acid and Structural Development To Increase Potency
  58. Anti-oxidative, anti-tumor-promoting, and anti-carcinogenic activities of adonirubin and adonixanthin
  59. Effect of a Peroxynitrite Scavenger, a Manganese-Porphyrin Compound on Airway Remodeling in a Murine Asthma
  60. Testicular Mineralization in KK-A<sup>y</sup> Mice Treated with an Oxovanadium Complex
  61. Iron overload signature in chrysotile-induced malignant mesothelioma
  62. The ferroimmunomodulatory role of ectopic endometriotic stromal cells in ovarian endometriosis
  63. Synthesis and structure–activity relationships of benzophenone-bearing diketopiperazine-type anti-microtubule agents
  64. RXR Partial Agonist CBt-PMN Exerts Therapeutic Effects on Type 2 Diabetes without the Side Effects of RXR Full Agonists
  65. Transient elevation of serum cystatin C concentrations during perioperative cisplatin-based chemotherapy in esophageal cancer patients
  66. Zinc Complexes Developed as Metallopharmaceutics for Treating Diabetes Mellitus based on the Bio-Medicinal Inorganic Chemistry
  67. Synthesis and Structure–Activity Relationship Study of Antimicrotubule Agents Phenylahistin Derivatives with a Didehydropiperazine-2,5-dione Structure
  68. Development of a Highly Sensitive Methodology for Quantitative Determination of Fexofenadine in a Microdose Study by Multiple Injection Method Using Ultra-High Performance Liquid Chromatography with Tandem Mass Spectrometry
  69. Feasibility of Structural Modification of Retinoid X Receptor Agonists to Separate Blood Glucose-Lowering Action from Adverse Effects: Studies in KKA<sup>y</sup> Type 2 Diabetes Model Mice
  70. In vitro insulin-mimetic activity and in vivo metallokinetic feature of oxovanadium(IV)porphyrin complexes in healthy rats
  71. <i>In Vitro</i> Study on the Transport of Zinc across Intestinal Epithelial Cells Using Caco-2 Monolayers and Isolated Rat Intestinal Membranes
  72. Pharmacological and Pharmacokinetic Studies of Anti-diabetic Tropolonato–Zn(II) Complexes with Zn(S<sub>2</sub>O<sub>2</sub>) Coordination Mode
  73. E10A, an adenovirus-carrying endostatin gene, dramatically increased the tumor drug concentration of metronomic chemotherapy with low-dose cisplatin in a xenograft mouse model for head and neck squamous-cell carcinoma
  74. Diameter and rigidity of multiwalled carbon nanotubes are critical factors in mesothelial injury and carcinogenesis
  75. ChemInform Abstract: Challenge of Studies on the Development of New Zn Complexes to Treat Diabetes Mellitus
  76. The disposition and intestinal absorption of zinc in rats
  77. Neuroprotective effect of a new DJ-1-binding compound against neurodegeneration in Parkinson's disease and stroke model rats
  78. Improved Spectrophotometric Determination of Total Iron and Iron(III) with <i>o</i>-Hydroxyhydroquinonephthalein and Their Characterization
  79. Novel carotenoid pyropheophorbide A esters from abalone
  80. Challenge of Studies on the Development of New Zn Complexes to Treat Diabetes Mellitus
  81. Detoxification of 6-hydroxydopamine-induced Parkinsonian neurodegeneration by G-CYPMPO, a novel radical trapper
  82. Efficient reduction of Cys110 thiyl radical by glutathione in human myoglobin
  83. Cellular Mechanism of Zinc–Hinokitiol Complexes in Diabetes Mellitus
  84. Challenge of studies on the development of new Zn complexes (Zn(opt)2) to treat diabetes mellitus
  85. Synthesis and in vitro insulin-mimetic activities of zinc(ii) complexes of ethyl 2,5-dihydro-4-hydroxy-5-oxo-1H-pyrrole-3-carboxylates
  86. Effects of Zn(ii) complex with vitamins C and U, and carnitine on metabolic syndrome model rats
  87. Development of a Novel High-Throughput Analytical Methodology, Multiple Injection Method, for Quantitative Analysis in Drug Metabolism and Pharmacokinetic Studies Using Liquid Chromatography with Tandem Mass Spectrometry
  88. Oral Administration of Bis(aspirinato)zinc(II) Complex Ameliorates Hyperglycemia and Metabolic Syndrome-Like Disorders in Spontaneously Diabetic KK-Ay Mice: Structure-Activity Relationship on Zinc-Salicylate Complexes
  89. Tubulin photoaffinity labeling study with a plinabulin chemical probe possessing a biotin tag at the oxazole
  90. Organ distribution of quantum dots after intraperitoneal administration, with special reference to area-specific distribution in the brain
  91. Anti-microtubule ‘plinabulin’ chemical probe KPU-244-B3 labeled both α- and β-tubulin
  92. Inhibitory effect of CuSO4 on α-glucosidase activity in ddY mice
  93. Synthesis of Metal Complexes with 1-Substituted 3-Hydroxy-2(1H)-pyridinethiones and Their Insulin-Mimetic Activities
  94. Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice
  95. Prevention of ischemia/reperfusion injury by hepatic targeting of nitric oxide in mice
  96. Alpha-glucosidase inhibitory effect of anti-diabetic metal ions and their complexes
  97. Evaluation of insulin-mimetic activities of vanadyl and zinc(II) complexes from the viewpoint of heterocyclic bidentate ligands
  98. Unidirectional Binding of Clostridial Collagenase to Triple Helical Substrates
  99. ChemInform Abstract: Current State for the Development of Metallopharmaceutics and Antidiabetic Metal Complexes
  100. Observing Systems Simulation Experiments on Abnormally High Surface Air Temperatures in the Tokyo Metropolitan Area Using WRF-VAR
  101. Protection Against Oxidative Stress-Induced Neurodegeneration by a Modulator for DJ-1, the Wild-Type of Familial Parkinson’s Disease-Linked PARK7
  102. Synthesis of Biotin-Tagged Diketopiperazine-Based Anti-Microtubule Agents and Tubulin Photoaffinity Labeling
  103. Synergistic effect of galantamine on nicotine-induced neuroprotection in hemiparkinsonian rat model
  104. Inhibitory Effects of Short-Chain Fatty Acids on Matrix Metalloproteinase Secretion from Human Colonic Subepithelial Myofibroblasts
  105. Photocontrol of Spatial Orientation and DNA Cleavage Activity of Copper(II)-Bound Dipeptides Linked by an Azobenzene Derivative
  106. Current state for the development of metallopharmaceutics and anti-diabetic metal complexes
  107. Visualization and characterization of UVB-induced reactive oxygen species in a human skin equivalent model
  108. Suppressive effect of orally administered copper(II)-aspirinate (Cu2(asp)4) complex on the generation of reactive oxygen species in the skin of animals subjected to UVA exposure
  109. Metallokinetic characteristics of antidiabetic bis(allixinato)oxovanadium(IV)-related complexes in the blood of rat
  110. Chemical Structure-Dependent Differential Effects of Flavonoids on the Catalase Activity as Evaluated by a Chemiluminescent Method
  111. Novel screening method for ultraviolet protection: Combination of a human skin-equivalent model and 8-hydroxy-2'-deoxyguanosine
  112. Generation and distribution of reactive oxygen species in the skin of hairless mice under UVA: studies on in vivo chemiluminescent detection and tape stripping methods
  113. A New Physiologically Based Pharmacokinetic Analysis for In Vivo Organ Disposition of Nitroxyl Spin Probes in Mice as Measured by Multisite Detection L-band ESR (MSD-LESR)
  114. A novel drug delivery system for type 1 diabetes: Insulin-mimetic vanadyl-poly(γ-glutamic acid) complex
  115. Oxovanadium(IV)–Porphyrin Complex as a Potent Insulin-Mimetic. Treatment of Experimental Type 1 Diabetic Mice by the Complex [meso-Tetrakis(4-sulfonatophenyl)porphyrinato]oxovanadate(IV)(4−)
  116. Real-time chemiluminescent imaging and detection of reactive oxygen species generated in the UVB-exposed human skin equivalent model
  117. Memory Deficit in Mice Administered Aluminum–maltolate Complex
  118. Suppressive Effect of Caffeic Acid and its Derivatives on the Generation of UVA-induced Reactive Oxygen Species in the Skin of Hairless Mice and Pharmacokinetic Analysis on Organ Distribution of Caffeic Acid in ddY Mice
  119. Orally active antioxidative copper(II) aspirinate: synthesis, structure characterization, superoxide scavenging activity, and in vitro and in vivo antioxidative evaluations
  120. Orally active antioxidative copper(II) aspirinate: synthesis, structure characterization, superoxide scavenging activity, and in vitro and in vivo antioxidative evaluations
  121. A New Type of Orally Active Insulin-mimetic Vanadyl-porphyrin Complex:meso-Tetrakis({4-sulfonatophenyl}porphyrinato)oxovanadium(IV)
  122. Effect of insulin-mimetic vanadyl sulfate on cytochrome P450 2E1-dependent p-nitrophenol hydroxylation in the liver microsomes of streptozotocin-induced type 1 diabetic rats
  123. Detection of reactive oxygen species in the skin of live mice and rats exposed to UVA light: a research review on chemiluminescence and trials for UVA protection
  124. Improvement of diabetic states in streptozotocin-induced type 1 diabetic rats by vanadyl sulfate in enteric-coated capsules
  125. Essential Role of Singlet Oxygen Species in Cytochrome P450-dependent Substrate Oxygenation by Rat Liver Microsomes
  126. Possible Involvement of Singlet Oxygen Species as Multiple Oxidants in P450 Catalytic Reactions
  127. Orally administrated aluminum–maltolate complex enhances oxidative stress in the organs of mice
  128. Spinnokinetic Analyses of Blood Disposition and Biliary Excretion of Nitric Oxide (NO)-Fe(II)-N-(Dithiocarboxy)sarcosine Complex in Rats: BCM-ESR and BEM-ESR Studies
  129. Pharmacokinetic Analysis of Ramatroban Using a Recirculatory Model with Enterohepatic Circulation by Measuring Portal and Systemic Blood Concentration Difference in Sprague-Dawley and Eisai Hyperbilirubinemic Rats
  130. A new candidate for insulinomimetic vanadium complex: synergism of oxovanadium(IV)porphyrin and sodium ascorbate
  131. Pharmacokinetic Study and Trial for Preparation of Enteric-Coated Capsule Containing Insulinomimetic Vanadyl Compounds: Implications for Clinical Use
  132. Specific Binding of Vanadyl Ion (VO2+) with Thiolate of the Cysteine-34 Residue in Serum Albumin, Demonstrated by CD Spectroscopy and Kinetic Property
  133. New antidiabetic vanadyl–pyridone complexes: effect of equivalent transformation of coordinating atom in the ligand
  134. Age-dependent generation of reactive oxygen species in the skin of live hairless rats exposed to UVA light
  135. The therapeutic potential of insulin-mimetic vanadium complexes
  136. A Recirculatory Model with Enterohepatic Circulation by Measuring Portal and Systemic Blood Concentration Difference
  137. Structure-activity relationship of insulinomimetic vanadyl-picolinate complexes in view of their clinical use
  138. A New Determination Method of Nitric Oxide (NO) with a NO-selective Electrode Demonstrated by the Kinetic Analysis of NO Generation and Decomposition
  139. Structure-dependent metallokinetics of antidiabetic vanadyl-picolinate complexes in rats: studies on solution structure, insulinomimetic activity, and metallokinetics
  140. Enteric-coating capsulation of insulinomimetic vanadyl sulfate enhances bioavailability of vanadyl species in rats
  141. Antidiabetic vanadium(IV) and zinc(II) complexes
  142. Topological Stability and Self-Association of a Completely Hydrophobic Model Transmembrane Helix in Lipid Bilayers
  143. A Recirculatory Model for Local Absorption and Disposition of Ciprofloxacin by Measuring Portal and Systemic Blood Concentration Difference
  144. Direct Reaction between Shikonin and Thiols Induces Apoptosis in HL60 Cells.
  145. Evidence for Singlet Oxygen Involvement in Rat and Human Cytochrome P450-dependent Substrate Oxidations
  146. Local Pharmacokinetic Analysis of a Stable Spin Probe in Mice by In Vivo L-band ESR with Surface-coil-type Resonators
  147. Metallokinetic Study of Zinc in the Blood of Normal Rats Given Insulinomimetic Zinc(II) Complexes and Improvement of Diabetes Mellitus in Type 2 Diabetic GK Rats by their Oral Administration
  148. Pharmacokinetic study on gastrointestinal absorption of insulinomimetic vanadyl complexes in rats by ESR spectroscopy
  149. A new halogenated antidiabetic vanadyl complex, bis(5-iodopicolinato)oxovanadium(IV): in vitro and in vivo insulinomimetic evaluations and metallokinetic analysis
  150. Effects of static magnetic field on dissolved oxygen levels in aqueous solutions containing copper(II), iron(II), and heme iron(III) complexes
  151. An orally active antidiabetic vanadyl complex, bis(1-oxy-2-pyridinethiolato)oxovanadium(IV), with VO(S2O2) coordination mode; in vitro and in vivo evaluations in rats
  152. Chemiluminescent Detection and Imaging of Reactive Oxygen Species in Live Mouse Skin Exposed to UVA
  153. Metallokinetic analysis of disposition of vanadyl complexes as insulin-mimetics in rats using BCM-ESR method
  154. Data Analysis Methods
  155. A New Type of Orally Active Insulin-Mimetic Vanadyl Complex: Bis(1-oxy-2-pyridinethiolato)oxovanadium(IV) with VO(S2O2) Coordination Mode
  156. Involvement of Singlet Oxygen in Cytochrome P450-Dependent Substrate Oxidations
  157. ESR characterization and metallokinetic analysis of Cr(V) in the blood of rats given carcinogen chromate(VI) compounds
  158. Effect of HSP47 on Prolyl 4-Hydroxylation of Collagen Model Peptides.
  159. In vivoL-band ESR and quantitative pharmacokinetic analysis of stable spin probes in rats and mice
  160. Insulin-mimetic vanadyl—dithiocarbamate complexes
  161. HTHQ (1-O-hexyl-2,3,5-trimethylhydroquinone), an anti-lipid-peroxidative compound: its chemical and biochemical characterizations
  162. Moment Analysis of Stereoselective Enterohepatic Circulation and Unidirectional Chiral Inversion of Ketoprofen Enantiomers in Rat
  163. Moment Analysis of Stereoselective Biliary Excretion and Chiral Inversion of Ketoprofen Enantiomers in Perfused Rat Liver
  164. New hepatocellular diffusion model for analysis of hepatobiliary transport processes of drugs
  165. Effect of Temperature in Perfusate on Local Hepatic Disposition of BOF-4272, a New Xanthine Oxidase Inhibitor.
  166. Alternative Continuous Infusion Method for Analysis of Enterohepatic Circulation and Biliary Excretion of Cefixime in the Rat
  167. Moment analysis of hepatic local disposition of allopurinol and oxipurinol: metabolism kinetics from allopurinol to oxipurinol in the rat isolated perfused liver
  168. Local Disposition of a New Xanthine Oxidase/Xanthine Dehydrogenase Inhibitor, BOF-4272, in Rat Liver.
  169. Improved Flow Injection Analysis (FIA) Method for Determining Selenium in Biological Samples, and the Effect of Captopril Administration on Selenium Levels and Glutathione Peroxidase Activity in Rat.
  170. Synthetic Study on Selenocystine-Containing Peptides.
  171. Analysis of arterial–venous blood concentration difference of drugs based on recirculatory theory with fast inverse laplace transform (FILT)